Teahose.
SIGN IN
NEW HERE — WHAT TEAHOSE DOES
We read the entire AI & tech firehose — so you don't have to.
PODPodcastsAll-In, No Priors, Acquired…
NEWNewslettersStratechery, Newcomer…
PAPPapersPhysical AI research
PHProduct Huntdaily launches
VCInvestor ScoutSequoia, a16z, Benchmark…
CLAUDE DISTILLS →
7 reads, 30 sec each — free, 6 AM ET.
+ a live graph of the companies, people & themes underneath.
HOME/PEOPLE/NORMAN SHARPLESS
// PERSON

Norman Sharpless

ROLE HEAD OF CREATION STRATEGIESAT HATTERAS VENTURE PARTNERSMENTIONS 1LAST SEEN OCTOBER 1, 2026
// BIO

Norman "Ned" Sharpless is a physician-scientist and former Director of the National Cancer Institute who currently serves as Managing Director of Hatteras Discovery Innovation at Hatteras Venture Partners. He previously served as Acting Commissioner of the U.S. Food and Drug Administration and was director of the UNC Lineberger Comprehensive Cancer Center. He is best known for his research on aging and cancer, including the development of the p16LUC model, and for co-founding G1 Therapeutics, which developed the FDA-approved drug Cosela.

// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
hire·Axios Pro Rata·OCTOBER 1, 2026

“named former National Cancer Institute director Ned Sharpless as head of creation strategies.”

AI-extracted from podcast / newsletter / paper summaries. May contain errors.

Norman Sharpless — 1 mention on Teahose